Hershberger RE - Search Results

1

Pharmacologic and hemodynamic effects of combined beta-agonist stimulation and phosphodiesterase inhibition in the failing human heart.

Gilbert EM, Hershberger RE, Wiechmann RJ, Movsesian MA, Bristow MR. Gilbert EM, et al. Among authors: hershberger re. Chest. 1995 Dec;108(6):1524-32. doi: 10.1378/chest.108.6.1524. Chest. 1995. PMID: 7497755

2

A1-adenosine receptor inhibition of adenylate cyclase in failing and nonfailing human ventricular myocardium.

Hershberger RE, Feldman AM, Bristow MR. Hershberger RE, et al. Circulation. 1991 Apr;83(4):1343-51. doi: 10.1161/01.cir.83.4.1343. Circulation. 1991. PMID: 1901530

3

Neurotransmitter depletion compromises the ability of indirect-acting amines to provide inotropic support in the failing human heart.

Port JD, Gilbert EM, Larrabee P, Mealey P, Volkman K, Ginsburg R, Hershberger RE, Murray J, Bristow MR. Port JD, et al. Among authors: hershberger re. Circulation. 1990 Mar;81(3):929-38. doi: 10.1161/01.cir.81.3.929. Circulation. 1990. PMID: 1968367

4

Beta-adrenergic pathways in nonfailing and failing human ventricular myocardium.

Bristow MR, Hershberger RE, Port JD, Gilbert EM, Sandoval A, Rasmussen R, Cates AE, Feldman AM. Bristow MR, et al. Among authors: hershberger re. Circulation. 1990 Aug;82(2 Suppl):I12-25. Circulation. 1990. PMID: 2164894 Review.

5

Vasoactive intestinal peptide receptor in failing human ventricular myocardium exhibits increased affinity and decreased density.

Hershberger RE, Anderson FL, Bristow MR. Hershberger RE, et al. Circ Res. 1989 Aug;65(2):283-94. doi: 10.1161/01.res.65.2.283. Circ Res. 1989. PMID: 2546693

6

Beta 1- and beta 2-adrenergic receptor-mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium.

Bristow MR, Hershberger RE, Port JD, Minobe W, Rasmussen R. Bristow MR, et al. Among authors: hershberger re. Mol Pharmacol. 1989 Mar;35(3):295-303. Mol Pharmacol. 1989. PMID: 2564629

7

Heterogeneous regulatory changes in cell surface membrane receptors coupled to a positive inotropic response in the failing human heart.

Bristow MR, Ginsburg R, Gilbert EM, Hershberger RE. Bristow MR, et al. Among authors: hershberger re. Basic Res Cardiol. 1987;82 Suppl 2:369-76. doi: 10.1007/978-3-662-11289-2_36. Basic Res Cardiol. 1987. PMID: 2821984

8

Effect of vasoactive intestinal peptide on myocardial contractility and coronary blood flow in the dog: comparison with isoproterenol and forskolin.

Anderson FL, Kralios AC, Hershberger R, Bristow MR. Anderson FL, et al. J Cardiovasc Pharmacol. 1988 Sep;12(3):365-71. doi: 10.1097/00005344-198809000-00016. J Cardiovasc Pharmacol. 1988. PMID: 2464111

9

Desensitization of myocardial but not coronary VIP receptor-mediated responses in dogs.

Anderson FL, Kralios AC, Hershberger R, Bristow MR. Anderson FL, et al. Am J Physiol. 1988 Sep;255(3 Pt 2):H601-7. doi: 10.1152/ajpheart.1988.255.3.H601. Am J Physiol. 1988. PMID: 2843056

10

Effect of therapeutic dopamine administration on myocardial catecholamine and neuropeptide Y concentrations in the failing ventricles of patients with idiopathic dilated cardiomyopathy.

Anderson FL, Port JD, Reid BB, Hanson G, Kralios AC, Hershberger RE, Bristow MR. Anderson FL, et al. Among authors: hershberger re. J Cardiovasc Pharmacol. 1992;20(5):800-6. J Cardiovasc Pharmacol. 1992. PMID: 1280744

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

205 results

Search Page

Filters